Previous Article | Next Article 
Applied and Environmental Microbiology, December 1998, p. 4803-4808, Vol. 64, No. 12
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Two-Component Anti-Staphylococcus aureus
Lantibiotic Activity Produced by Staphylococcus aureus
C55
Maduwe A. D. B.
Navaratna,1
Hans-Georg
Sahl,2 and
John R.
Tagg1,*
Department of Microbiology, University of
Otago, Dunedin, New Zealand,1 and
Institut für Medizinische Mikrobiologie und
Immunologie der Universität Bonn, D-53105 Bonn,
Germany2
Received 10 April 1998/Accepted 11 September 1998
Staphylococcus aureus C55 was shown to produce
bacteriocin activity comprising three distinct peptide components,
termed staphylococcins C55
, C55
, and C55
. The three peptides
were purified to homogeneity by a simple four-step purification
procedure that consisted of ammonium sulfate precipitation followed by
XAD-2 and reversed-phase (C8 and C18)
chromatography. The yield following C8 chromatography was
about 86%, with a more-than-300-fold increase in specific activity.
When combined in approximately equimolar amounts, staphylococcins C55
and C55
acted synergistically to kill S. aureus or Micrococcus luteus but not S. epidermidis strains. The N-terminal amino acid sequences of all
three peptides were obtained and staphylococcins C55
and C55
were
shown to be lanthionine-containing (lantibiotic) molecules with
molecular weights of 3,339 and 2,993, respectively. The C55
peptide
did not appear to be a lantibiotic, nor did it augment the inhibitory
activities of staphylococcin C55
and/or C55
. Plasmids of 2.5 and
32.0 kb are present in strain C55, and following growth of this strain
at elevated temperature (42°C), a large proportion of the progeny
failed to produce strong bacteriocin activity and also lost the 32.0-kb
plasmid. Protoplast transformation of these bacteria with purified
32-kb plasmid DNA regenerates the ability to produce the strong
bacteriocin activity.
*
Corresponding author. Mailing address: Department of
Microbiology, University of Otago, P. O. Box 56, Dunedin, New
Zealand. Phone: 64 3 479 7714. Fax: 64 3 479 8540. E-mail:
john.tagg{at}stonebow.otago.ac.nz.
Applied and Environmental Microbiology, December 1998, p. 4803-4808, Vol. 64, No. 12
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Begley, M., Cotter, P. D., Hill, C., Ross, R. P.
(2009). Identification of a Novel Two-Peptide Lantibiotic, Lichenicidin, following Rational Genome Mining for LanM Proteins. Appl. Environ. Microbiol.
75: 5451-5460
[Abstract]
[Full Text]
-
He, Z., Kisla, D., Zhang, L., Yuan, C., Green-Church, K. B., Yousef, A. E.
(2007). Isolation and Identification of a Paenibacillus polymyxa Strain That Coproduces a Novel Lantibiotic and Polymyxin. Appl. Environ. Microbiol.
73: 168-178
[Abstract]
[Full Text]
-
McClerren, A. L., Cooper, L. E., Quan, C., Thomas, P. M., Kelleher, N. L., van der Donk, W. A.
(2006). Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. Proc. Natl. Acad. Sci. USA
103: 17243-17248
[Abstract]
[Full Text]
-
Sibbald, M. J. J. B., Ziebandt, A. K., Engelmann, S., Hecker, M., de Jong, A., Harmsen, H. J. M., Raangs, G. C., Stokroos, I., Arends, J. P., Dubois, J. Y. F., van Dijl, J. M.
(2006). Mapping the Pathways to Staphylococcal Pathogenesis by Comparative Secretomics. Microbiol. Mol. Biol. Rev.
70: 755-788
[Abstract]
[Full Text]
-
Cotter, P. D., Draper, L. A., Lawton, E. M., McAuliffe, O., Hill, C., Ross, R. P.
(2006). Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147.. Appl. Environ. Microbiol.
72: 4492-4496
[Abstract]
[Full Text]
-
Hale, J. D. F., Ting, Y.-T., Jack, R. W., Tagg, J. R., Heng, N. C. K.
(2005). Bacteriocin (Mutacin) Production by Streptococcus mutans Genome Sequence Reference Strain UA159: Elucidation of the Antimicrobial Repertoire by Genetic Dissection. Appl. Environ. Microbiol.
71: 7613-7617
[Abstract]
[Full Text]
-
Morgan, S. M., O'Connor, P. M., Cotter, P. D., Ross, R. P., Hill, C.
(2005). Sequential Actions of the Two Component Peptides of the Lantibiotic Lacticin 3147 Explain Its Antimicrobial Activity at Nanomolar Concentrations. Antimicrob. Agents Chemother.
49: 2606-2611
[Abstract]
[Full Text]
-
Yonezawa, H., Kuramitsu, H. K.
(2005). Genetic Analysis of a Unique Bacteriocin, Smb, Produced by Streptococcus mutans GS5. Antimicrob. Agents Chemother.
49: 541-548
[Abstract]
[Full Text]
-
Melancon, D., Grenier, D.
(2003). Production and Properties of Bacteriocin-Like Inhibitory Substances from the Swine Pathogen Streptococcus suis Serotype 2. Appl. Environ. Microbiol.
69: 4482-4488
[Abstract]
[Full Text]
-
Stein, T., Borchert, S., Conrad, B., Feesche, J., Hofemeister, B., Hofemeister, J., Entian, K.-D.
(2002). Two Different Lantibiotic-Like Peptides Originate from the Ericin Gene Cluster of Bacillus subtilis A1/3. J. Bacteriol.
184: 1703-1711
[Abstract]
[Full Text]
-
Holo, H., Jeknic, Z., Daeschel, M., Stevanovic, S., Nes, I. F.
(2001). Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics. Microbiology
147: 643-651
[Abstract]
[Full Text]
-
McAuliffe, O., Hill, C., Ross, R. P.
(2000). Identification and overexpression of ltnI, a novel gene which confers immunity to the two-component lantibiotic lacticin 3147. Microbiology
146: 129-138
[Abstract]
[Full Text]
-
Ryan, M. P., Jack, R. W., Josten, M., Sahl, H.-G., Jung, G., Ross, R. P., Hill, C.
(1999). Extensive Post-translational Modification, Including Serine to D-Alanine Conversion, in the Two-component Lantibiotic, Lacticin 3147. J. Biol. Chem.
274: 37544-37550
[Abstract]
[Full Text]